Takeda said today it is opening a subsidiary in Peru, after already establishing a presence in Brazil, Mexico, Argentina, Venezuela, Colombia and Ecuador. Citing IMS Market Prognosis statistics, the company said drug sales in those countries hit $60 billion in 2012 and are expected to grow at a compound annual rate of 12.5% between 2013 and 2017.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”